HSA
AMPH icon

Hussman Strategic Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hussman Strategic Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63,000
Closed -$1.23M – 240
2026
Q1 		$1.23M Buy
+63,000
New +$1.54M 0.27% 172
2025
Q2 		– Sell
-31,500
Closed -$913K – 216
2025
Q1 		$913K Buy
+31,500
New +$1.01M 0.22% 170
2024
Q3 		– Sell
-63,000
Closed -$2.52M – 225
2024
Q2 		$2.52M Hold
63,000
– – 0.69% 49
2024
Q1 		$2.77M Buy
+63,000
New +$3.25M 0.64% 62

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hussman Strategic Advisors's AMPH Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 63,000 shares — an estimated $1.23M sold.

Hussman Strategic Advisors first reported a position in AMPH in Q1 2024 and held it in 4 quarters. The position peaked at $2.77M in Q1 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Hussman Strategic Advisors reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 63,000 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.23M.
  • Hussman Strategic Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • Hussman Strategic Advisors's Amphastar Pharmaceuticals position peaked at $2.77M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.